| Document |
Document Title |
|
WO/2020/085373A1 |
The present invention provides a novel compound which has activating activity selective for ERĪ². A compound represented by formula (1) or a salt thereof. (In the formula, R1 represents a cycloalkyl group having 3-8 carbon atoms, an alke...
|
|
WO/2020/084456A1 |
The present invention is method of using a smart patch, with analyte testing capabilities, to test a wearer's sweat for the levels of various cannabinoids and delivering at least one other cannabinoid to the user from a reservoir in the ...
|
|
WO/2020/078743A1 |
The present inventions relates to the preparation of 3,3,5-trimethylcyclohexylidene bisphenol. Especially, the present invention relates to the preparation of 3,3,5- trimethylcyclohexylidene bisphenol from 3,3,5-trimethylcyclohexanone an...
|
|
WO/2020/081405A1 |
Compounds and methods related to the prevention and treatment of diseases and conditions, some of which are facilitated by melanogenesis are disclosed. Specifically, the present subject matter includes a series of compounds and compositi...
|
|
WO/2020/078369A1 |
Provided are a phenolic derivative, preparation method therefor and use thereof. The phenolic derivative has a structure as shown in formula (I), and the definitions of the groups therein are shown in the description. The phenolic deriva...
|
|
WO/2020/077451A1 |
The disclosure relates to porous and non-porous silica capsules (capsules in capsule or core-shell capsules), porous microspheres, as well as their direct phase emulsification process without surfactant and their use, wherein the particl...
|
|
WO/2020/080558A1 |
The present invention relates to compounds of the formula (I), which are suitable as monomers for preparing thermoplastic resins having beneficial optical properties and which can be used for producing optical devices: where A1, A2 are s...
|
|
WO/2020/077462A1 |
The present invention provides a powdered botanical extract preparation comprising an evenly distributed dispersion of a botanical extract in a methylsulfonylmethane matrix, processes for preparing the preparations, and dosage forms comp...
|
|
WO/2020/061703A1 |
The present disclosure relates to cannabinoid-containing product for human consumption having an improved taste profile and to methods of manufacturing same. The present disclosure also relates to a process for making a cannabinoid-conta...
|
|
WO/2020/061687A1 |
According to embodiments herein, pharmaceutically active cannabis-based compositions and methods of use for treating gastrointestinal conditions are provided. More specifically, a cannabis-based pharmaceutical composition and methods of ...
|
|
WO/2020/059624A1 |
Provided are: a monofunctional phenol compound that makes it possible to obtain an active ester resin that makes it possible to form a cured product that has excellent dielectric characteristics and heat resistance; an active ester resin...
|
|
WO/2020/055678A1 |
The present application discloses methods for the efficient preparation of high purity compounds of the Formula I, and their methods of use.
|
|
WO/2020/051186A1 |
A process for producing bisphenol-A comprises reacting acetone and phenol in the presence of a catalyst system comprising an acidic heterogeneous catalyst and a catalyst promoter comprising at least one organic sulfur-containing compound...
|
|
WO/2020/051371A2 |
The present disclosure relates to the preparation of a highly pure cannabidiol compound by a novel synthesis route. The cannabidiol compound can be prepared by an acid-catalyzed reaction of a di-halo olivetol with menthadienol, followed ...
|
|
WO/2020/048751A1 |
The present invention relates to the preparation of 3,3,5 -trimethylcyclohexylidene bisphenol (BP-TMC). Especially, the present invention relates to the preparation of 3,3,5-trimethylcyclohexylidene bisphenol (BP-TMC) from 3,3,5 -trimeth...
|
|
WO/2020/051554A1 |
A resorcinol with modifications at the 2-position is provided. The reactant resorcinol may have a variety of functional groups at each of the 1, 3, and 5 position such as a hydroxide, a lower alkyl group, a phenyl, a substituted phenyl, ...
|
|
WO/2020/046494A1 |
A process for the preparation of a 2,6-di(C1-7 alkyl)phenol composition includes reacting phenol and a C1-7 alkyl alcohol in the presence of a catalyst to form the 2,6-di(C1-7 alkyl)phenol; and isolating the 2,6-di(C1-7 alkyl)phenol comp...
|
|
WO/2020/044121A1 |
Described herein are cannabinoid formulations in combination with phenylalanine for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof and manufacturin...
|
|
WO/2020/044123A1 |
Described herein are cannabinoid formulations in combination with Boswellia extract for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof and manufact...
|
|
WO/2020/041860A1 |
An aqueous alkaline composition comprising a cannabinoid which may be cannabidiol (CBD) used alone or in combination with other cannabinoids. An alkalizing agent which comprises pico size carbon particles is present in the composition, i...
|
|
WO/2020/042766A1 |
A GABA A receptor allosteric enhancer compound and preparation and a use thereof are disclosed. The compound has a structure represented by formula (1). R 1 and R 2 are each independently selected from isopropyl and n-propyl; and when R ...
|
|
WO/2020/044116A1 |
Described herein are cannabinoid formulations in combination with curcumin for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof and manufacturing ora...
|
|
WO/2020/044118A1 |
Described herein are cannabinoid formulations for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof.
|
|
WO/2020/041877A1 |
Systems and methods of extracting compounds from botanical matter are provided. The system includes: a solvent source; an extraction vessel which receives botanical matter from which compounds, including at least one target compound are ...
|
|
WO/2020/037413A1 |
The present disclosure relates to a cannabinoid based emulsification system for infusing a non-aqueous composition with a cannabinoid, the emulsification system comprising: a) at least one cannabinoid in a carrier oil; b) a plurality of ...
|
|
WO/2020/037372A1 |
A method of detecting the presence of an NBOMe in a sample which comprises of contacting the sample with an activated p-quinone such as 2,3,5,6-tetrachloro-1,4-benzoquinone (TCBQ) and an aldehyde, for example acetaldehyde, and optionally...
|
|
WO/2020/037410A1 |
The present disclosure relates to a cannabis-infused product, comprising an emulsion containing a cannabinoid profile including one or more cannabinoid, wherein the emulsion is a nanoemulsion. The disclosure also relates to methods of ma...
|
|
WO/2020/037409A1 |
The present disclosure relates to a cannabis-infused product comprising a cannabinoid profile including one or more cannabinoid, a first composition for controlling onset of the cannabinoid profile and a second composition for extending ...
|
|
WO/2020/040161A1 |
Provided is a composition containing a polyphenol compound (B), wherein the polyphenol compound (B) is one or more resins selected from the group consisting of resins having the structure represented by formula (1) and resins having the ...
|
|
WO/2020/037412A1 |
The present disclosure relates to a cannabinoid based dry or aqueous self-emulsification system for infusing a composition with a cannabinoid. The self-emulsification system comprises: a) at least one cannabinoid in a carrier oil; b) a p...
|
|
WO/2020/040162A1 |
Provided is a composition containing a polyphenol compound (B), wherein the polyphenol compound (B) is one or more substances selected from the group consisting of compounds having the structure represented by formula (1) and resins havi...
|
|
WO/2020/037402A1 |
A dosage device that includes a cannabinoid-containing substance enables controlled addition of the cannabinoid-containing substance to a liquid to produce a cannabinoid-containing liquid for ingestion. In an embodiment, such a dosage de...
|
|
WO/2020/037408A1 |
The present disclosure relates to a cannabis-infused product comprising a cannabinoid profile including one or more cannabinoid, a first composition for controlling onset of the cannabinoid profile and a second composition for controllin...
|
|
WO/2020/036248A1 |
Disclosed in the present specification is an apparatus for recycling wood or lignin and a method for producing phenol from wood or lignin using same. The apparatus for recycling wood or lignin, according to one aspect of the present inve...
|
|
WO/2020/037163A1 |
Disclosed herein are isotactic polyvinyl ethers and improved methods of making same. The method disclosed herein can produce polyvinyl ethers having a higher isotacticity as compared to polyvinyl ethers prepared with conventional methods.
|
|
WO/2020/028991A1 |
The invention relates to methods for producing botanical extracts comprising cannabinoids and terpenes using cold extraction with highly polyunsaturated lipid solvents. These methods allow for the extraction of cannabinoids and terpenes ...
|
|
WO/2020/028992A1 |
The invention relates to methods of producing extracts from cannabis plant material, where the extracts comprise cannabinoids and terpenes. The methods comprise extracting fresh or dried plant material with a cold organic solvent. The me...
|
|
WO/2020/030541A1 |
The present invention relates to a novel solid presentation form of a phenol derivative, characterized by a rounded portion and a flat portion. The compositions thus obtained have advantageous properties suitable for the storage, handlin...
|
|
WO/2020/032102A1 |
The present invention addresses the problem of providing: a thermosetting resin-based composition having good curability; and a thermosetting resin-based cured product having good adhesion and heat resistance. To solve the problem, an on...
|
|
WO/2020/033859A1 |
Various aspects of this disclosure relate to methods to lower the activation energy of the cannabinoid decarboxylation reaction by performing the decarboxylation reaction in the gas phase.
|
|
WO/2020/025781A1 |
The present invention relates to a cocrystal of ubiquinone and a hydrogen bond donor coformer, to a process for the preparation thereof, and to its use as a medicament or a dietary supplement. The invention also relates to compositions c...
|
|
WO/2020/027206A1 |
This composition includes a polyphenol compound (B) and a solvent, wherein the polyphenol compound (B) is at least one selected from among a compound represented by formula (1) and a resin having a structure represented by formula (2). (...
|
|
WO/2020/024056A1 |
The present technology generally relates to a composition for topical administration or for oral administrations. The composition comprises at least one cannabinoid and at least one absorbable material. In some instances, the at least on...
|
|
WO/2020/014776A1 |
An oral dispersible film composition comprising at least one active ingredient and a film forming agent, as well as a method of manufacture of same. The oral dispersible film composition can be free of gum resin, and can be utilized to a...
|
|
WO/2020/014709A1 |
Disclosed are anti-avian pathogenic E. coli (APEC) agents as well as methods of using thereof.
|
|
WO/2020/008051A1 |
The present invention relates to a compound of the following formula (I): (I). The invention also relates to uses thereof as dye or pigment, notably as a luster pigment,and to areflective or photonic or nanophotonic or optoelectronic dev...
|
|
WO/2020/009705A1 |
A method is disclosed for treating a residual stream from bisphenol manufacture, wherein the residual stream comprises unreacted phenols, bisphenol isomers, trisphenols, organic sulfides and water. The method comprises contacting at leas...
|
|
WO/2020/004207A1 |
The present invention addresses the problem of providing a crystalline body of 9,9-bis(4-hydroxyphenyl)-2,3-benzofluorene, which has a specific melting point, and is not an inclusion body or has a remaining organic solvent content of 1% ...
|
|
WO/2020/001770A1 |
The present invention relates to a method of producing a compound of formula (I) or a salt of a compound of formula (I). The invention also relates to a compound of formula (I) or a salt of a compound of formula (I) for use in a therapeu...
|
|
WO/2019/242010A1 |
Provided is a compound or a salt thereof as a linking chain. The compound or a salt thereof can be loaded onto a solid-phase resin for solid-phase synthesis of a polypeptide drug, thereby improving the synthetic yield of the polypeptide ...
|
